Digital Twin of the Aorta

Digital Twin of the Aorta

BioPharma Digital Twin of the Aorta The technology simulates blood flow so surgeons can test their approach before they operate. Scientists at Queen Mary University of London have created TAVR-AID, a digital twin of the aorta specific to each patient, which simulates...
Predicting Pre-Eclampsia

Predicting Pre-Eclampsia

BioPharma Predicting Pre-Eclampsia Pre-eclampsia, a condition affecting pregnant women, remains poorly understood despite affecting up to one in ten pregnancies worldwide. The condition kills 70,000 mothers and half a million babies globally each year. If diagnosed...
Predicting dementia nine years before symptoms

Predicting dementia nine years before symptoms

BioPharma Predicting dementia nine years before symptoms Researchers at Queen Mary’s Centre of Preventive Neurology have developed a new method for predicting dementia with over 80% accuracy and up to nine years before a diagnosis. The new method provides a more...
Enhancing the efficacy of immunotherapy in lung cancer

Enhancing the efficacy of immunotherapy in lung cancer

BioPharma Enhancing the efficacy of immunotherapy in non-small cell lung cancer using an RGD-mimetic Queen Mary scientists led by Prof Kairbaan Hodivala-Dilke have invented a new methodology for treating lung cancer – the leading cause of cancer deaths...
Single molecule biochips

Single molecule biochips

Technology & Engineering Single molecule biochips Acute Traumatic Coagulopathy, a term first coined by Queen Mary’s Karim Brohi in 2003, occurs when traumatic bleeding leads to abnormal blood clotting. The result is more severe bleeding, organ failure, and death....